Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 1 Trials

Duarte, California

Phase 1 colorectal cancer trials in Duarte, CA

25 Phase 1 colorectal cancer studies are recruiting participants at sites in Duarte as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.

Call (888) 415-5976
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Duarte at a glance

  • 25 studies are recruiting at a site in Duarte.
  • By phase: Phase 1 (21), Phase 1/2 (4).
  • By sponsor: industry (22), university, hospital or other (3).
  • Most recent update to one of these records: November 17, 2026.

Studies recruiting in Duarte

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Aktis Oncology, Inc.
    Study site
    City of Hope
    Registry record
    NCT07020117 · updated
  2. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Vividion Therapeutics, Inc.
    Study site
    City of Hope Cancer Center
    Registry record
    NCT06004245 · updated
  3. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Study site
    City of Hope Comprehensive Cancer Center
    Registry record
    NCT07503808 · updated
  4. A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    City of Hope Comprehensive Cancer Center
    Registry record
    NCT04929223 · updated
  5. A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study site
    City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
    Registry record
    NCT07318805 · updated
  6. A Study of LY4257496 in Participants With Cancer (OMNIRAY)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    City of Hope
    Registry record
    NCT07114601 · updated
  7. Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    City of Hope Medical Center
    Study site
    City of Hope Medical Center
    Registry record
    NCT06130826 · updated
  8. LYL273 for Patients With Relapsed or Refractory mCRC

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Lyell Immunopharma, Inc.
    Study site
    City of Hope Comprehensive Cancer Center
    Registry record
    NCT05319314 · updated
  9. Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    BigHat Biosciences, Inc.
    Study site
    City of Hope Duarte
    Registry record
    NCT07529808 · updated
  10. A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Bayer
    Study site
    City of Hope - Duarte Cancer Center
    Registry record
    NCT07535112 · updated
  11. A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Dispatch Biotherapeutics
    Study site
    City of Hope
    Registry record
    NCT07544589 · updated
  12. Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
    Study site
    City of Hope Comprehensive Cancer Center
    Registry record
    NCT06625775 · updated
  13. A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT05877599 · updated
  14. Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Phanes Therapeutics
    Study site
    City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
    Registry record
    NCT05482893 · updated
  15. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    EvolveImmune United, Inc
    Study site
    City of Hope
    Registry record
    NCT07217171 · updated
  16. Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

    • Phase 1
    • Ages 12 to 85
    • All sexes
    Sponsor
    Inhibrx Biosciences, Inc
    Study site
    City of Hope
    Registry record
    NCT03715933 · updated
  17. PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    City of Hope Medical Center
    Study site
    City of Hope Medical Center
    Registry record
    NCT04329494 · updated
  18. A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Cartography Biosciences
    Study site
    City of Hope Duarte
    Registry record
    NCT07321106 · updated
  19. Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Xencor, Inc.
    Study site
    Xencor Investigative Site
    Registry record
    NCT05433142 · updated
  20. AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Amgen
    Study site
    City of Hope National Medical Center
    Registry record
    NCT07094113 · updated
  21. A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Seagen, a wholly owned subsidiary of Pfizer
    Study sites
    City of Hope (City of Hope National Medical Center, City of Hope Medical Center) · IP Address: City of Hope Investigational Drug Services(IDS)
    Registry record
    NCT06131840 · updated
  22. Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    City of Hope Medical Center
    Study site
    City of Hope Medical Center
    Registry record
    NCT06834126 · updated
  23. A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Coherus Oncology, Inc.
    Study site
    City of Hope
    Registry record
    NCT06657144 · updated
  24. Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    City of Hope National Medical Center /ID# 276272
    Registry record
    NCT05005403 · updated
  25. 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

    • Phase 1/2
    • Ages 15 and older
    • All sexes
    Sponsor
    Lantheus Medical Imaging
    Study site
    City of Hope
    Registry record
    NCT06298916 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Duarte, CA on ClinicalTrials.gov.

Ask about studies near Duarte

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in California

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 415-5976

or send a short form

How should we reach you?

Call